Reaction
Red Blood Cell Abnormality reporting signals
As of the last recalculation, Red Blood Cell Abnormality appears in 954 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is FEBUXOSTAT TABLETS 40 MG (PRR 30.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Febuxostat Tablets 40 Mg | 14 | 30.5 | 30.5 |
| Febuxostat Tablets 80 Mg | 14 | 30.5 | 30.5 |
| Niraparib | 21 | 21.1 | 21.1 |
| Febuxostat | 14 | 18.5 | 18.5 |
| Zidovudine | 11 | 18.1 | 18.2 |
| Romiplostim | 12 | 17.6 | 17.6 |
| Nevirapine | 7 | 17.0 | 17.1 |
| Daspone | 7 | 15.8 | 15.8 |
| Dapsone Gel, 5% | 7 | 15.8 | 15.8 |
| Ruxolitinib | 45 | 14.3 | 14.3 |
| Efavirenz | 7 | 13.8 | 13.8 |
| Deferasirox | 14 | 11.7 | 11.7 |
| Olaparib | 11 | 11.6 | 11.6 |
| Pazopanib Hydrochloride | 13 | 10.6 | 10.6 |
| Eculizumab | 22 | 9.0 | 9.0 |
| Peginterferon Alfa-2A | 21 | 8.6 | 8.6 |
| Prasugrel Hydrochloride | 4 | 8.6 | 8.6 |
| Eltrombopag Olamine | 9 | 8.6 | 8.6 |
| Avapritinib | 4 | 7.2 | 7.2 |